Literature DB >> 32127513

Subacute Thyroiditis: An Unusual Presentation of Fever of Unknown Origin Following Upper Respiratory Tract Infection.

Mustafa Akram Al-Tikrity1, Mohamed Magdi1, Abdul-Badi Abou Samra1,2, Abdel-Naser Y Elzouki1,2,3.   

Abstract

BACKGROUND Fever of unknown origin (FUO) is a diagnosis that requires a demanding workup from physicians before confirming a diagnosis. Thyroid diseases are a rare cause of FUO. Subacute thyroiditis is an inflammatory disease that can lead to a wide spectrum of presentations. CASE REPORT We report a case of a previously healthy male who presented with persistent fever of 4 weeks following an upper respiratory tract infection associated with constitutional symptoms. His laboratory workup included complete blood counts (CBC), complete metabolic panel (blood urea and creatinine, liver function tests, and serum electrolytes), blood cultures, abdominal and pelvic ultrasound, and computed tomography abdomen and pelvis that were inconclusive. His thyroid function tests showed a hyperthyroid state and a thyroid scan confirmed a picture of thyroiditis. The patient was treated with Ibuprofen and then with prednisolone; he showed significant improvement over a few days and was discharged with treatment of tapering doses of prednisolone over 6 weeks. Two weeks after discharge the patient had a follow-up at an outpatient clinic and was found to be in good health with resolution of his symptoms. CONCLUSIONS Thyroid disorders are not a common cause of FUO, and even if the clinical assessment of the patient is not suggestive of thyroid disease, we should consider it a possible cause. and thyroid function test should be performed to exclude thyroid problems.

Entities:  

Year:  2020        PMID: 32127513      PMCID: PMC7069329          DOI: 10.12659/AJCR.920515

Source DB:  PubMed          Journal:  Am J Case Rep        ISSN: 1941-5923


Background

Thyroiditis is an inflammatory condition of the thyroid gland that consists of 3 main types. The first type is acute suppurative thyroiditis, which is a bacterial infection of the gland. The second type is subacute thyroiditis, which usually follows a viral infection. The third type is chronic thyroiditis, which is an autoimmune inflammation [1]. Subacute thyroiditis is an uncommon condition with an incidence of 4.9 cases per 100 000 population per year; it is a self-limiting disease that may last 2 to 7 months [2]. Thyroiditis usually has several phases: hyper-thyroidism, which is the typical presentation, followed by an euthyroid state, followed by a hypothyroid state, and ultimately the restoration of normal thyroid function. Each phase lasts several weeks. Therefore, regular monitoring of the thyroid function is important to confirm the resolution of hyper-thyroidism, to detect and follow the hypothyroid state and follow the subsequent normalization of thyroid function [2]. Thyroiditis has a wide spectrum of presentations. The most common clinical features are neck pain, thyroid tenderness on palpation, and a diffuse goiter (diffusely enlarged gland) [3-5]. Although fever and constitutional symptoms are common in this disease, persistent fever without neck pain or thyroid tenderness is a rare presentation. We report here a case of a patient with subacute thyroiditis who presented after a history of upper respiratory tract infection with fever of unknown origin (FUO), without neck pain, tenderness of the thyroid gland or goiter. We also reviewed the literature related to the patient’s presentation. FUO is defined as fever higher than 38.3ºC on several occasions for a duration of more than 3 weeks with uncertain or provisional diagnosis after 1 week of hospital evaluation [6]. Classically, infections, malignancies, and connective tissue diseases constitute the major causes. However, many cases have no definite diagnosis. A prospective multicenter study in the Netherlands [7] showed interesting percentages for different etiologies of FUO. Infection-related causes were found in up to 16% of cases, while neoplastic causes were found in 7% of cases. Others causes, such as noninfectious inflammatory conditions, were found in 22% of the cases, while miscellaneous causes were found in 4% of cases, interestingly, in 51% of the cases, no obvious cause of fever was found.

Case Report

A 44-year-old male known to have hypertension, presented with fever for 4 weeks. The fever was daily, came in spikes, and was associated with chills, generalized fatigability, and odynophagia. He reported a weight loss of 3 kg for the same duration. Ten days before his presentation, he had a runny nose and sore throat which resolved with symptomatic treatment. He denied having a cough, chest pain, palpitation, heat intolerance, change in bowel habits, sick contact, or recent travel. There was no history of unprotected sexual contact. He did not smoke or consume alcohol. The patient had no history of intravenous drug use; he had no family history of thyroid diseases. He had been treated at another hospital where his complete blood counts (CBC), serum electrolytes, kidney and liver function tests, blood cultures, abdominal and pelvic ultrasound and computed tomography of the abdomen and pelvis were inconclusive. He received 2 different consecutive courses of antibiotics for 7–10 days, each without clinical improvement. He presented to our hospital with the persistence of his symptoms and more fatigue and persistent fever. On examination, he was in distress, fever of 38.5°C, heart rate of 100 beats per minute, and blood pressure of 130/80 mmHg. Neck examination showed no thyromegaly or lymphadenopathy. General and systemic examination was unremarkable. Laboratory investigations showed hemoglobin 12 g/dL, WBC 11 000, erythrocyte sedimentation rate (ESR) 57 mm/hour, C-reactive protein (CRP) 102 mg/L, thyroid stimulating hormone (TSH) 0.01 mIU/L (Table 1) and negative anti-thyroid peroxidase. An autoimmune workup that includes antinuclear antibodies (ANA) was negative. The respiratory viral panel was done, and it was negative. Multiple sets of blood cultures, a urine culture, 2 malaria blood films (thin and thick), viral hepatitis serology (A, B, C, and E), brucella and human immunodeficiency virus (HIV) screening were negative. The patient’s chest x-ray was normal, and a repeated ultrasound of the abdomen and pelvis was un-remarkable. Thyroid scintigraphy showed decreases uptake in both lobes suggestive of thyroiditis.
Table 1.

Laboratory findings of the patient at presentation and after treatment.

At presentationHospital course4 weeks after discharge12 weeks after dischargeNormal range
WBC count11 00012 000850060004000–11 000
ESR575020<30 mm/hr
CRP1021768570–5 mg/L
TSH<0.01<0.010.120.540.30–4.50 mIU/L
Free T44637.721.211.6–21.9 pmol/L
Free T3136.25.52.5–6.5 pmol/L

WBC – white blood cell; ESR – erythrocyte sedimentation rate; CRP – C-reactive protein; TSH – thyroid stimulating hormone.

Treatment was initiated with Ibuprofen 400 mg twice daily for 3 days but there was only minimal improvement in his symptoms. Consequently, prednisolone 40 mg daily was given and after 2 days he showed significant improvement of clinical condition with no fever reported. The patient was discharged on prednisolone tapering dose for 6 weeks with outpatient follow up. After 2 weeks, he was seen in the outpatient clinic and found to be in good health, with resolution of his symptoms. Repeated blood laboratory tests after 4 weeks showed gradual improvement in TSH levels, with a normal level after 12 weeks. The ultrasound of the thyroid performed 1 month after discharge showed a heterogeneous thyroid, suggestive of a post-inflammatory period. The right lobe nodule, which was 0.8×0.7 cm, had minimal internal vascularity, no calcifications, and no evidence of regional infiltrations.

Discussion

Subacute thyroiditis is a granulomatous inflammation of the thyroid gland. Other names for it are sub-acute nonsuppurative thyroiditis, de Quervain’s thyroiditis, painful thyroiditis, and giant cell thyroiditis. Subacute thyroiditis can be secondary to viral upper respiratory tract infection. Many viruses have been identified as the cause, such as coxsackie virus, mumps virus, measles virus, and adenovirus [8]. Some cases have shown a strong association with HLA-B35. Our patient had a history of sore throat 10 days before his presentation to our hospital which resolved with symptomatic treatment. The main clinical presentation of subacute thyroiditis is neck pain [2]. The pain can be confined to the thyroid area or radiating through the neck to the jaw, throat, ears, or upper chest. An enlarged tender thyroid gland is usually found on palpation during the examination. Fever and constitutional symptoms are common as well. Symptoms of hyperthyroidism are found in 50% of cases [2]. Our patient did not exhibit neck pain or thyroid tenderness, but his main concerning complaints were persistent fever and fatigue, and on examination, he did not have a palpable thyroid gland or cervical lymphadenopathy. Diagnosis is usually clinical and later confirmed with laboratory tests for hyperthyroidism which is seen in nearly all patients, and a high ESR, which can be >50 mm/hour and may exceed 100 mm/hour, or elevated CRP, and reduced radioio-dine uptake in thyroid scan [4]. Ultrasound, if performed, may show enlarged and hypoechoic thyroid glands with reduced vascularity and irregular margin. In our patient both ESR and CRP were high, and both were helpful markers for monitoring treatment response, in addition to signs of clinical improvement. A study on the prevalence of elevated CRP in differentiating inflammatory from non-inflammatory thyroid disease found that elevated CRP is always found in subacute thyroiditis. Other findings may include mild anemia and leukocytosis. Liver function tests can be abnormal during the initial phase of the hyperthyroid state. Although our patient’s liver function tests were normal, he had mild leukocytosis and mild anemia, which were resolved after treatment initiation. A radioiodine imaging of the thyroid gland can show low up-take (usually less than 1% to 3%) or a minimal heterogeneous uptake of radionuclide uptake during the early stage. On ultrasonography, the thyroid can be normal size or enlarged but will be diffusely or focally hypoechogenic. Ultrasound of the thyroid gland of our patient at 1 month after discharge showed features of post-inflammatory changes supporting previous inflammation. Therapy, if needed, is usually directed toward relief of thyroid pain and tenderness, and alleviating symptoms of fever and myalgia as well as inflammation. It is usually practice to started with oral non-steroidal anti-inflammatory drugs (NSAID) and if there are no improvements in pain in 2 to 3 days, steroids therapy should be initiated. Our patient did not show signs of improvement on naproxen over 3 days; consequently, prednisolone was started, after which the patient showed significant improvement within a few days. Following recovery from the transient hyperthyroid state, a few patients may develop hypothyroidism which requires lifelong hormonal replacement therapy with levothyroxine [3]. Thyroid diseases are considered among the rare causes of FUO. After searching the literature, we found a number reported cases of subacute thyroiditis, mainly published after the year 2000, where patients presented with FUO [9-17]. Table 2 shows the main clinical and biochemical features and outcomes of the 8 cases. The age range was between 40 and 81 years, have male predominant. Almost all the cases had some associated symptoms with fever. Some of cases in the literature responded to NSAIDs or a short course of prednisolone (10 mg daily for 1 to 2 weeks), but due to persistence of symptoms despite the use of NSAID, or due to severe disease, a higher dose with prolonged duration of steroid might be needed to get better response and outcome, as was shown in 2 cases and the present case (see Table 2). The current treatment of subacute thyroiditis in patients who present with the fever that is prolonged is usually guided by the assigned clinician. Treatment is mainly symptomatic with analgesics to control the inflammation and pain, and beta-blockers to control symptoms of hyperthyroidism.
Table 2.

Summary of reported subacute thyroiditis cases in presented the literature as pyrexia of unknown origin.

CaseAgeGenderMain symptomsExamLabsMain TreatmentOutcome
Alexander et al. (2009) [9]43MaleFever, neck pain for 1 month, no H/O if URTIGoiter, tremorsESR: 123TSH: 0.0001FT 4: 46NSAIDs and beta-blocker at first but no response; prednisolone 60 mg for 2 weeks then tapper for 1 monthHypothyroidism
Cunha et al. (2010) [10]55FemaleFever, night sweats for 1 month; H/O URTIESR: 98CRP: 84Ferritin: 611TSH: 0.009FT4: 2.1ATG: pos.Not mentionedNot mentioned
Weiss et al. (2000) [11]81MaleFever, confusion, and bilateral lower extremity weaknessESR: 98TSH: 0.02FT4: 3.1FT3: 6.0Beta-blockerProfound hypothyroidism at 3 months; euthyroidism at 14 months
Karachalios et al. (2010) [12]72MaleFever, malaise for 1 monthNo findingsERS: 102CRP: 52TSH: 0.024FT4: 185ATG: neg.Low dose steroid dose (prednisolone 10 mg), showed good responseNot mentioned
Kim et al. (2013) [13]48/FemaleFever, neck painESR: 65TSH 0. 065CRP 2.07Prednisone 10 mg per day (intravenous)Hypothyroidism after 3 weeks
Burke et al. (2013) [14]67FemaleFever, myalgia, headache, and arthralgiaESR: 79TSH: 0.018T4: normal,ATG: normalA 2-week course of corticosteroid therapyAfter 2 weeks, TSH level and ESR returned to normal. The patient was asymptomatic
Muqtadir et al. (2015) [15]40MaleFever for 2 monthsUnremarkableESR: 90TSH: 0.02FT4: 3.66ATG: neg.Prednisolone 10 mg for 10 days then stopped without taperingNot mentioned
Raj et al. (2018) [16]80MaleFever, headache, recurrent fallsSinus tachycardia with a grade 2/6 systolic ejection murmur in the aortic areaESR: 86CRP 192TSH: 0.01Total T4: 13.4Prednisone 40 mg dailyNot mentioned
Dalugama (2018) [17]42MaleFever, malaise weight loss or 3 weeksBilateral cervical lymphadenopathy; anterior neck tenderness; no thyromegalyESR: 80CRP: 112TSH: 0.012FT4: 42Prednisolone 10 mg for one week then stoppedEuthyroidism
Present case40MaleFever, chill, fatigabilityUnremarkableESR: 57CRP: 102TSH: <0.01Total T4: 49Prednisolone 40 mgEuthyroid

URTI – upper respiratory tract infection; H/O – history of; ESR – erythrocyte sedimentation rate (mm/hr); CRP – C-reactive protein (mg/L); TSH – thyroid stimulating hormone (μIU/mL); Total T4 (pmol/L); ATG – anti-thymocyte globulin (neg/pos/normal).

Conclusions

In conclusion, although thyroid disorders are not a common cause of FUO, initial workup should include thyroid function tests even if the clinical picture is not suggestive of hyperthyroidism. FUO has a wide spectrum of causes ranging from infectious causes to inflammatory and autoimmune conditions, which make the diagnosis sometimes challenging and subacute thyroiditis (a thyroid disorder) is one of the challenging conditions. Therefore, initial workup should include thyroid function tests even if the clinical picture is not suggestive of hyperthyroidism.
  15 in total

Review 1.  Thyroiditis.

Authors:  Elizabeth N Pearce; Alan P Farwell; Lewis E Braverman
Journal:  N Engl J Med       Date:  2003-06-26       Impact factor: 91.245

2.  A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol.

Authors:  Chantal P Bleeker-Rovers; Fidel J Vos; Elisabeth M H A de Kleijn; Aart H Mudde; Ton S M Dofferhoff; Clemens Richter; Tineke J Smilde; Paul F M Krabbe; Wim J G Oyen; Jos W M van der Meer
Journal:  Medicine (Baltimore)       Date:  2007-01       Impact factor: 1.889

3.  Subacute thyroiditis (de Quervain's) due to influenza A: presenting as fever of unknown origin (FUO).

Authors:  Burke A Cunha; Nicholas Berbari
Journal:  Heart Lung       Date:  2012-07-17       Impact factor: 2.210

4.  Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study.

Authors:  Vahab Fatourechi; Jaroslaw P Aniszewski; Guiti Z Eghbali Fatourechi; Elizabeth J Atkinson; Steven J Jacobsen
Journal:  J Clin Endocrinol Metab       Date:  2003-05       Impact factor: 5.958

Review 5.  Hyperthyroidism.

Authors:  David S Cooper
Journal:  Lancet       Date:  2003-08-09       Impact factor: 79.321

6.  Fever of unknown origin (FUO): de Quervain's subacute thyroiditis with highly elevated ferritin levels mimicking temporal arteritis (TA).

Authors:  Burke A Cunha; Azfar Chak; Stephanie Strollo
Journal:  Heart Lung       Date:  2009-09-03       Impact factor: 2.210

7.  Fever of Unknown Origin as a Sole Presentation of Subacute Thyroiditis in an Elderly Patient: A Case Report with Literature Review.

Authors:  Rishi Raj; Srujana Yada; Aasems Jacob; Dileep Unnikrishnan; Wael Ghali
Journal:  Case Rep Endocrinol       Date:  2018-10-25

Review 8.  Viruses and thyroiditis: an update.

Authors:  Rachel Desailloud; Didier Hober
Journal:  Virol J       Date:  2009-01-12       Impact factor: 4.099

9.  Subacute thyroiditis: clinical presentation and long term outcome.

Authors:  Assim A Alfadda; Reem M Sallam; Ghadi E Elawad; Hisham Aldhukair; Mossaed M Alyahya
Journal:  Int J Endocrinol       Date:  2014-04-03       Impact factor: 3.257

10.  Asymptomatic thyroiditis presenting as pyrexia of unknown origin: a case report.

Authors:  Chamara Dalugama
Journal:  J Med Case Rep       Date:  2018-02-23
View more
  4 in total

1.  An Elderly Woman with Pyrexia of Unknown Origin.

Authors:  Dimitrios Anyfantakis; Fani Katsanikaki; Serafim Kastanakis
Journal:  Maedica (Bucur)       Date:  2020-06

Review 2.  New aspects in the pathogenesis and management of subacute thyroiditis.

Authors:  Magdalena Stasiak; Andrzej Lewiński
Journal:  Rev Endocr Metab Disord       Date:  2021-05-05       Impact factor: 6.514

Review 3.  Thyroid dysfunction following vaccination with COVID-19 vaccines: a basic review of the preliminary evidence.

Authors:  A Jafarzadeh; M Nemati; S Jafarzadeh; P Nozari; S M J Mortazavi
Journal:  J Endocrinol Invest       Date:  2022-03-26       Impact factor: 5.467

4.  C-reactive protein and thyroid-stimulating hormone levels as risk factors for hypothyroidism in patients with subacute thyroiditis.

Authors:  Chenjia Tang; Yanting Dong; Lusi Lu; Nan Zhang
Journal:  Endocr Connect       Date:  2021-08-13       Impact factor: 3.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.